18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.

Clinical trial NCT06335069 · RECRUITING

Trial details

NCT number: NCT06335069
Sponsor: Maastricht University Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Neoplasms Breast Diseases

Start date: 2025-09-01
Primary completion: 2027-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.